2019
DOI: 10.5045/br.2019.54.2.149
|View full text |Cite
|
Sign up to set email alerts
|

False elevations of vitamin B12 levels due to assay errors in a patient with pernicious anemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…al reported that normal serum cobalamin cannot exclude functional cobalamin deficiency 3 . High titer of anti‐intrinsic factor antibodies can interfere with cobalamin immunoassays, giving a falsely high result, as in our case 4 . Second‐line tests such as homocysteine, methylmalonic acid, and holotranscobalamin are useful in cases with strong clinical suspicion but with normal serum cobalamin.…”
Section: Discussionmentioning
confidence: 77%
See 1 more Smart Citation
“…al reported that normal serum cobalamin cannot exclude functional cobalamin deficiency 3 . High titer of anti‐intrinsic factor antibodies can interfere with cobalamin immunoassays, giving a falsely high result, as in our case 4 . Second‐line tests such as homocysteine, methylmalonic acid, and holotranscobalamin are useful in cases with strong clinical suspicion but with normal serum cobalamin.…”
Section: Discussionmentioning
confidence: 77%
“…3 High titer of anti-intrinsic factor antibodies can interfere with cobalamin immunoassays, giving a falsely high result, as in our case. 4 Second-line tests such as homocysteine, methylmalonic acid, and holotranscobalamin are useful in cases with strong clinical suspicion but with normal serum cobalamin. Vitamin B12 deficiency and MDS are difficult to differentiate on bone marrow examination as both have similar morphological dyserythropoietic changes.…”
Section: Discussionmentioning
confidence: 99%
“…Since the 1990s, clinical laboratories have opted for high throughput automated competitive binding chemiluminescence assays (CBLA), using purified IF as a reagent, to measure total cobalamin after its release from endogenous binding proteins [103]. Caution should however be observed when interpreting results, since some of these assays could be influenced by the presence of interfering anti-IF antibodies, particularly in patients with PA, thereby providing spuriously elevated serum cobalamin concentrations in otherwise B 12 -deficient patients [104][105][106].…”
Section: Serum B 12 Testmentioning
confidence: 99%